Financials
- Market Capitalization 1.74 B
- Employee 140
- Founded 2011
- CEO N/A
- Website www.absci.com
- Headquarter Washington, United States
- FIGI BBG011N54CJ8
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-4.15
ratio cours/chiffre d'affaires
170.48
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 2037 | ZBIO Zenas BioPharma, Inc. - Common Stock | 27.26 USD | +3.89% | -4.25% | -12.06% | +3.02% | 1.78 B USD | ||
| 2046 | NUVB Nuvation Bio Inc. Class A Common Stock | 5.00 USD | +0.40% | -1.96% | -15.25% | +31.93% | 1.76 B USD | ||
| 2083 | OCUL Ocular Therapeutix, Inc. - Common Stock | 7.54 USD | +0.40% | +8.80% | -28.93% | -34.43% | 1.66 B USD | ||
| 2108 | STOK Stoke Therapeutics, Inc. - Common Stock | 24.74 USD | +3.30% | -4.18% | -15.79% | -18.03% | 1.60 B USD |